Identifying a Deletion Affecting Total Lung Capacity Among Subjects in the COPDGene Study Cohort.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 26643968)

Published in Genet Epidemiol on December 07, 2015

Authors

Ferdouse Begum1, Ingo Ruczinski2, Shengchao Li3, Edwin K Silverman4, Michael H Cho4, David A Lynch5, Douglas Curran-Everett6, James Crapo5, Robert B Scharpf7, Margaret M Parker1, Jacqueline B Hetmanski1, Terri H Beaty1

Author Affiliations

1: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
2: Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
3: Cancer Genomics Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, United States of America.
4: Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
5: Department of Medicine, National Jewish Health, Denver, Colorado, United States of America.
6: Division of Biostatistics and Bioinformatics, National Jewish Health, Denver, Colorado, United States of America.
7: Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

Associated clinical trials:

Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints (ECLIPSE) | NCT00292552

Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) (COPDGene) | NCT00608764

Articles cited by this

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol (1989) 37.83

Towards a proteome-scale map of the human protein-protein interaction network. Nature (2005) 24.76

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96

Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50

PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res (2007) 19.07

STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res (2012) 18.26

LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics (2010) 13.54

The Genotype-Tissue Expression (GTEx) project. Nat Genet (2013) 10.77

High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res (2006) 10.45

Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67

Standardisation of the measurement of lung volumes. Eur Respir J (2005) 7.48

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J (2008) 4.53

Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms. Nucleic Acids Res (2008) 4.22

Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet (2010) 3.44

The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med (2007) 2.91

Fast computation and applications of genome mappability. PLoS One (2012) 2.73

Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med (2014) 2.28

A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet (2011) 1.98

Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med (2011) 1.76

Accurate airway wall estimation using phase congruency. Med Image Comput Comput Assist Interv (2006) 1.62

Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J (2009) 1.61

Interobserver variability in the determination of upper lobe-predominant emphysema. Chest (2007) 1.49

Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res (2014) 1.06

Deaths: Leading Causes for 2011. Natl Vital Stat Rep (2015) 1.00

Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. Respir Res (2013) 1.00

Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature. Eur J Hum Genet (2014) 0.99

Genomic copy number determines functional expression of {beta}-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 0.97

A genome-wide study of de novo deletions identifies a candidate locus for non-syndromic isolated cleft lip/palate risk. BMC Genet (2014) 0.88

Pulmonary hyperinflation a clinical overview. Eur Respir J (1996) 0.88

Fast detection of de novo copy number variants from SNP arrays for case-parent trios. BMC Bioinformatics (2012) 0.86

A GC-wave correction algorithm that improves the analytical performance of aCGH. J Mol Diagn (2012) 0.84

[Dynamic lung hyperinflation and its clinical implication in COPD]. Rev Mal Respir (2008) 0.84

Copy number variation of the beta-defensin genes in europeans: no supporting evidence for association with lung function, chronic obstructive pulmonary disease or asthma. PLoS One (2014) 0.83

Copy number polymorphisms near SLC2A9 are associated with serum uric acid concentrations. BMC Genet (2014) 0.83

Genome-wide association study of copy number variations associated with pulmonary function measures in Korea Associated Resource (KARE) cohorts. Genomics (2010) 0.82

DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease. Respir Res (2014) 0.82

Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study. Genet Epidemiol (2014) 0.82

The phenotypic spectrum of duplication 5q35.2-q35.3 encompassing NSD1: is it really a reversed Sotos syndrome? Am J Med Genet A (2013) 0.81

PLEIAD/SIMC1/C5orf25, a novel autolysis regulator for a skeletal-muscle-specific calpain, CAPN3, scaffolds a CAPN3 substrate, CTBP1. J Mol Biol (2013) 0.80

Genetic syndromes associated with overgrowth in childhood. Ann Pediatr Endocrinol Metab (2013) 0.77